Compare IVA & CRI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | IVA | CRI |
|---|---|---|
| Founded | 2011 | 1865 |
| Country | | US |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Apparel |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.3B | 1.3B |
| IPO Year | N/A | 2002 |
| Metric | IVA | CRI |
|---|---|---|
| Price | $6.69 | $41.96 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 10 | 5 |
| Target Price | $16.20 | ★ $32.60 |
| AVG Volume (30 Days) | 518.7K | ★ 1.1M |
| Earning Date | 01-01-0001 | 04-12-2026 |
| Dividend Yield | N/A | ★ 2.44% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.75 |
| Revenue | N/A | ★ $2,844,102,000.00 |
| Revenue This Year | N/A | $2.49 |
| Revenue Next Year | N/A | $0.21 |
| P/E Ratio | ★ N/A | $54.99 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $2.70 | $23.38 |
| 52 Week High | $7.98 | $54.58 |
| Indicator | IVA | CRI |
|---|---|---|
| Relative Strength Index (RSI) | 63.61 | 71.44 |
| Support Level | $5.95 | $37.28 |
| Resistance Level | $6.37 | $38.84 |
| Average True Range (ATR) | 0.30 | 1.60 |
| MACD | -0.03 | 0.44 |
| Stochastic Oscillator | 98.00 | 97.98 |
Inventiva SA is a France-based biopharmaceutical company specialized in developing drugs that impact on nuclear receptors, transcription factors and epigenetic modulation. The company is focused on developing its product candidate, lanifibranor, for the treatment of patients with non-alcoholic steatohepatitis, or NASH, a disease for which there are currently no approved therapies. The company is also involved in developing a portfolio of pre-clinical therapy programs. It operates in the segment of Service delivery and clinical stage research, notably into therapies in the areas of oncology, fibrosis, and rare diseases. All the company's operations are in France. Majority of the group's revenue is derived from its research partnerships with AbbVie and BI.
Carter's Inc makes apparel for babies and children under brand names including Carter's and OshKosh B'gosh. It sells its products through a multi-channel business model, which includes retail stores, eCommerce, and wholesale sales channels, as well as retail omnichannel capabilities in the United States and Canada, which enables it to reach a broad range of consumers around the world. The company operates in three segments; U.S. Retail, U.S. Wholesale, and International. The majority of revenue is derived from U.S. Wholesale segment. The company predominantly sources products through contract manufacturers in Asia. It has multiple distribution centers in the U.S., in addition to distribution centers in Canada and Asia that serve international customers.